235 related articles for article (PubMed ID: 11952865)
1. A study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features.
Hanson IM; Banerjee SS; Menasce LP; Prescott RJ
Histopathology; 2002 Feb; 40(2):187-95. PubMed ID: 11952865
[TBL] [Abstract][Full Text] [Related]
2. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
3. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
Romano RC; Carter JM; Folpe AL
Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum.
Plaza JA; Torres-Cabala C; Evans H; Diwan HA; Suster S; Prieto VG
Am J Dermatopathol; 2010 Apr; 32(2):129-36. PubMed ID: 20010406
[TBL] [Abstract][Full Text] [Related]
5. Combined high-grade basal cell carcinoma and malignant melanoma of the skin ("malignant basomelanocytic tumor"): report of two cases and review of the literature.
Rodriguez J; Nonaka D; Kuhn E; Reichel M; Rosai J
Am J Dermatopathol; 2005 Aug; 27(4):314-8. PubMed ID: 16121052
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous neuroendocrine (Merkel cell) carcinoma occurred after resection of malignant melanoma.
Fang X; Wang Z; Li Y
J Dermatol; 2001 Mar; 28(3):153-7. PubMed ID: 11349467
[TBL] [Abstract][Full Text] [Related]
7. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study.
Kontochristopoulos GJ; Stavropoulos PG; Krasagakis K; Goerdt S; Zouboulis CC
Dermatology; 2000; 201(2):123-6. PubMed ID: 11053914
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
[TBL] [Abstract][Full Text] [Related]
10. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail.
Orchard G
Br J Biomed Sci; 2002; 59(4):196-202. PubMed ID: 12572952
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
[TBL] [Abstract][Full Text] [Related]
13. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
14. CUTANEOUS POLYPOID MELANOMA OF HEAD AND NECK.
Wollina U; Hansel G; Schönlebe J
Georgian Med News; 2018 May; (278):68-71. PubMed ID: 29905548
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma metastatic to a basal cell carcinoma simulating the pattern of a basomelanocytic tumor.
Busam KJ; Halpern A; Marghoob AA
Am J Surg Pathol; 2006 Jan; 30(1):133-6. PubMed ID: 16330954
[TBL] [Abstract][Full Text] [Related]
16. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
Tran TAN; Linos K; de Abreu FB; Carlson JA
Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
18. Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis.
Blessing K; Grant JJ; Sanders DS; Kennedy MM; Husain A; Coburn P
J Clin Pathol; 2000 Aug; 53(8):591-5. PubMed ID: 11002761
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
Eyden B; Pandit D; Banerjee SS
Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
[TBL] [Abstract][Full Text] [Related]
20. Metastatic small cell malignant melanoma: a case requiring immunoelectronmicroscopy for the demonstration of lattice-deficient melanosomes.
Eyden B; Moss J; Shore I; Banerjee SS
Ultrastruct Pathol; 2005; 29(1):71-8. PubMed ID: 15931781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
